Research assistant professor of Medicine Jilian Melamed is focused on researching mRNA as a means of combating celiac disease, type one diabetes, multiple sclerosis ... and it can alter from a vaccine ...
News-Medical.Net on MSN6d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback